See, Gerard Lee L.
See, Gerard Lee L.
Dean | School of Health Care Professions
Full Professor
Degrees
B.S. Pharmacy, University of San Carlos, 2011
M.S. Pharmacy, University of San Carlos, 2014
Ph.D. Pharmaceutical Sciences, Josai University, 2019
Post-doctoral program (transdermal drug delivery), Josai University, 2020
Research Interests:
Drug development, drug delivery, pharmacokinetics, nanotechnology
Selected recent publications:
1. Flores, K. A., Okada, A., Arce, F., Jr, See, G. L., Itakura, S., Todo, H., Sugibayashi, K. (2024). Development of an Auraptene-Loaded Transdermal Formulation Using Non-ionic Sugar Ester Surfactants. Chemical & Pharmaceutical Bulletin, 72(3), 319–323. https://doi.org/10.1248/cpb.c23-00796
2. Sakdiset, P.; Arce, F.; See, G. L.; Sawatdee, S.; Sae Yoon, A. (2023). Preparation and characterization of lidocaine HCl-loaded proniosome gels with skin penetration enhancers. J. Drug Delivery Sci. Technol., 86. https://doi.org/10.1016/j.jddst.2023.104639
3. Inoue, Y.; Nanri, A.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Yokogawa, T.; Kitamura, M. (2023). Preparation and spectroscopic characterization of ternary inclusion complexes of ascorbyl palmitate and urea with γ-cyclodextrin. Chem. Engineer., 7(2), 29. https://doi.org/10.3390/chemengineering7020029
4. Sakurai, H.; Suzuki, M.; Itakura, S.; Todo, H.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2022). Preparation, characterization, solubility, and antioxidant capacity of ellagic acid-urea complex. Materials, 15(8), 2836.
5. Tachikawa, R.; Saito, H.; Moteki, H.; Kimura, M.; Kitagishi, H.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2022). Preparation, characterization, and in vitro evaluation of inclusion complexes formed between S-allylcysteine and cyclodextrins. ACS Omega, 7(35), 31233-31245. https://doi.org/10.1021/acsomega.2c03489
6. Inoue, Y.; Shigematsu, M.; Komatsu, T.; Oguchi, T.; Arce, F. J.; See, G. L. (2022). Preparation and spectroscopic characterization of inclusion complexes of 3D ball-milled rifampicin with beta-cyclodextrin and gamma-cyclodextrin. AAPS PharmSciTech, 23(5), 138.
7. Inoue, Y.; Yoshida, M.; Ezawa, T.; Tanikawa, T.; Arce, F. Jr.; See, G. L.; Tomita, J.; Suzuki, M.; Oguchi, T. (2021). Inclusion complexes of daidzein with cyclodextrin-based metal-organic-framework-1 enhance its solubility and antioxidant capacity. AAPS PharmSciTech, 23(1), 2.
8. Nanri, A.; Yoshida, M.; Ishida, Y.; Nakata, D.; Terao, K.; Arce, F. Jr.; See, G. L.; Tanikawa, T.; Inoue, Y. (2021). Preparation and characterization of a hybrid complex of cyclodextrin-based metal-organic-framework-1 and ascorbic acid derivatives. Materials, 14(23), 7309.
9. See, G. L.; Arce, F. V. J.; Dahlizar, S., Okada, A.; Fadli, MFBM; Hijikuro, S. et al. (2020). Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations. J. Control. Rel. 325, 1-9.
10. See, G. L.; Arce, F. V. J.; Itakura, S.; Todo, H.; Sugibayashi, K. (2020). Prolonged distribution of tranilast in the eyes after topical application onto eyelid skin. Chem. Pharm. Bull. 68(8), 779-783.
11. Arce, F. V. J.; Asano, N.; See, G. L.; Oshizaka, T.; Itakura, S.; Todo, H.; Sugibayashi, K. (2020). Prediction of skin permeation and concentration of rhododendrol applied as finite dose from complex cosmetic vehicles. Int. J. Pharm., 119186.